Pancreatic Cancer James S. Barthel, M.D. and Douglas P. Slakey, M.D., M.P.H. Identify pancreatic cysts, based on classification and characteristics. Determine the risk for malignancy of a pancreatic cyst, based on its classification and characteristics. Implement the International Association of Pancreatology consensus guidelines in the management of pancreatic cysts. Choose the appropriate imaging study to diagnose a neoplasm of the pancreas. Recognize the indications and appropriate time for surgery, depending on the type of pancreatic neoplasm.
Worms and Germs of the GI Tract John F. Fisher, M.D. Diagnose helminth infections through identification of eggs in stool specimens. Prevent transmission of helminths based on their life cycle and specific hosts. Recognize the risk factors for C difficile infection (CDI). Recommend methods to prevent transmission of C difficile. Manage recurrences and relapses of CDI with appropriate therapy.
Obesity Kerry Dunbar, M.D., Sarah Jane Schwarzenberg, M.D. and Suzanne Darnell, M.D. Explain the importance of compliance to diet as key to weight loss. Identify the safety issues associated with weight-loss medications. Recognize the requirements and contraindications of bariatric surgery in adolescents. Manage obese women with chronic or acute abnormal uterine bleeding. Choose the most appropriate contraceptive method for an obese woman.
GI Cancers John S. Bolton, M.D., David L. Carr–Locke, M.D. and Joseph F. Buell, M.D. Elaborate on the Bismuth classification of cholangiocarcinomas. Implement strategies to improve the R0 resection rate for cholangiocarcinomas. Discuss the characteristics of the ideal stent and the possible complications from using a stent in malignant disease. Describe operative approaches to cholangiocarcinoma. Recommend appropriate therapies for hepatocellular carcinoma.
Colorectal Cancer Elizabeth C. Wick, M.D. and Timothy M. Pawlik, M.D., M.P.H. Make the appropriate choice between radical resection and local excision to treat rectal cancer. Identify the indications for immediate salvage surgery. Explain the concept of condition survival. Elaborate on the indications for 2-stage hepatectomy. Discuss the importance of an adequate future liver remnant after surgery to remove hepatic metastases.
GI Hemorrhage Jack Di Palma, M.D. and John M. Carethers, M.D. Determine whether anticoagulants should be discontinued in a patient undergoing a high-risk endoscopic procedure. Recognize the indicators of major GI bleeding. Consider the use of prokinetics to clear the stomach of blood before endoscopy. Diagnose common causes of acute and chronic upper GI bleeding. Appropriately prescribe intravenous and oral proton pump inhibitors to reduce the risk for rebleeding.
IBD Part I: Debates and Compliance David T. Rubin, M.D., Marla Dubinsky, M.D. and Russell D. Cohen, M.D. Recognize that symptoms in CD often do not correlate with the degree of endoscopic disease. Discuss the results of various clinical trials in which mucosal healing was an end point. Describe the role of endoscopy in inflammatory bowel disease. Evaluate the methods of assessing disease activity in CD and whether endoscopic scores matter. Encourage patient compliance and adherence to medication regimens to improve outcomes and lower overall costs.
IBD Part II: Polyps and Psychologic Effects David T. Rubin, M.D. and Eva M. Szigethy, M.D., Ph.D. Recognize the risk factors for dysplasia in IBD. Adopt guidelines for cancer prevention in patients with ulcerative colitis and Crohn disease. Determine which patients with dysplasia should go to surgery. Discuss the association between IBD and psychologic factors. Recommend psychosocial treatment options for patients with IBD.
DDW Potpourri Tram T. Tran, M.D., Jordan J. Feld, M.D., M.P.H., Lee L. Swanstrom, M.D., Miguel Regueiro, M.D. and Victor Navarro, M.D. Implement vaccination and immunoprophylaxis to prevent perinatal transmission of HBV. Identify and manage patients at risk for HBV reactivation who require immunosuppression. Review the effects of successful Nissen fundoplication on Barrett esophagus. Recognize the indications for performing minimally invasive esophagectomy. Apply the treatment algorithm for patients with inflammatory bowel disease who have primary or secondary failure with infliximab.
Hepatitis C George Y. Wu, M.D., Ph.D. and Eric J. Lawitz, M.D. Differentiate the serologic pattern of acute HCV infection from that of chronic infection. Identify individuals who require screening for HCV. Recognize challenges in the study and treatment of HCV infection. Implement Âresponse-guided therapy for HCV infection and avoid drug resistance. Check for viral load at appropriate intervals during treatment of HCV infection.
Additional Continuing Education Options Available...
If you have taken the current Gastroenterology course listed above or if you are seeking additional Gastroenterology credits, please visit: Medical Courses Coming Soon. There you will find abbreviated listings of additional courses available and courses that will be available soon.
ASI Now Offers 9 NEW Specialties! Click the links below for the current course outline and full information!
What our clients are saying about American Seminar Institute..
"The ability to take my CME at my own pace and work it into my busy schedule was greatly appreciated...the lectures and course materials were of excellent quality. The whole CME experience was a pleasure." Sandra C. MD, Baltimore, MD
"Really loved this method of earning my CEUs!! ...your CME program allowed the perfect amount of flexibility while delivering current and useful information..I was able to earn my needed CEs while cruising the Caribbean." Norman, NP, St. Louis,MO
Back to Top of Gastroenterology CME Review Page
